Asia’s rapidly growing consumer class, the Cartel Jalisco Nueva Generación, and R&D patterns in the drug industry.
| 5 things to understand about pharmaceutical R&D At the heart of the policy debate around prescription drug prices is a concern that pricing policies would reduce revenues for pharmaceutical companies, thereby limiting their investments into the research and development (R&D) of new treatments. To find out if this concern is warranted, Richard Frank and Kathleen Hannick examine the data on R&D patterns in the drug industry. Read more |
| How Mexico’s Cartel Jalisco Nueva Generación rules Large segments of Mexico’s people, territory, and economy are falling under the rule of Mexican criminal groups. Drawing on her fieldwork in various parts of Mexico in October and November 2021, Vanda Felbab-Brown outlines some of the strategies that one of the largest criminal groups in the country, the Cartel Jalisco Nueva Generación, deploys and how it differs from Mexico’s other major criminal group, the Sinaloa cartel. Read more |
| Asia’s tipping point in the consumer class “Against commonly held wisdom, the global middle class in Asia has recovered strongly after the COVID shock in 2020. It continues to multiply and is already larger than before the pandemic,” find Wolfgang Fengler, Homi Kharas, and Juan Caballero. Read more |
Want to give feedback on the Brookings website? If you have two to three minutes, please complete this survey and let us know how we can improve our website. We appreciate your input! |
The conclusions and recommendations of any Brookings publication are solely those of its author(s), and do not reflect the views of the Institution, its management, or its other scholars. |
|
